1. Home
  2. PTCT vs BCO Comparison

PTCT vs BCO Comparison

Compare PTCT & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • BCO
  • Stock Information
  • Founded
  • PTCT 1998
  • BCO 1859
  • Country
  • PTCT United States
  • BCO United States
  • Employees
  • PTCT N/A
  • BCO N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • BCO Oil Refining/Marketing
  • Sector
  • PTCT Health Care
  • BCO Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • BCO Nasdaq
  • Market Cap
  • PTCT 4.1B
  • BCO 4.2B
  • IPO Year
  • PTCT 2013
  • BCO N/A
  • Fundamental
  • Price
  • PTCT $61.09
  • BCO $115.66
  • Analyst Decision
  • PTCT Buy
  • BCO Strong Buy
  • Analyst Count
  • PTCT 14
  • BCO 1
  • Target Price
  • PTCT $67.00
  • BCO $138.00
  • AVG Volume (30 Days)
  • PTCT 1.4M
  • BCO 294.5K
  • Earning Date
  • PTCT 11-06-2025
  • BCO 11-05-2025
  • Dividend Yield
  • PTCT N/A
  • BCO 0.88%
  • EPS Growth
  • PTCT N/A
  • BCO 24.94
  • EPS
  • PTCT 7.72
  • BCO 3.72
  • Revenue
  • PTCT $1,764,929,000.00
  • BCO $5,069,900,000.00
  • Revenue This Year
  • PTCT $119.89
  • BCO $5.33
  • Revenue Next Year
  • PTCT N/A
  • BCO $4.60
  • P/E Ratio
  • PTCT $7.91
  • BCO $31.37
  • Revenue Growth
  • PTCT 96.00
  • BCO 2.17
  • 52 Week Low
  • PTCT $31.80
  • BCO $80.10
  • 52 Week High
  • PTCT $62.18
  • BCO $117.65
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 75.37
  • BCO 67.12
  • Support Level
  • PTCT $57.47
  • BCO $113.91
  • Resistance Level
  • PTCT $58.73
  • BCO $115.68
  • Average True Range (ATR)
  • PTCT 2.04
  • BCO 2.15
  • MACD
  • PTCT 0.96
  • BCO -0.33
  • Stochastic Oscillator
  • PTCT 92.16
  • BCO 71.54

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.

Share on Social Networks: